Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News The Spectranetics Corporation SPNC

Healthcare Medical Devices
"The Spectranetics Corp manufactures and sells single-use medical devices which are used to cross, prepare, and treat arterial blockages in the legs and heart and to remove pacemaker and defibrillator cardiac leads."

Recent & Breaking News (NDAQ:SPNC)

Spectranetics Reports Third Quarter 2016 Revenue of $68.3 million

GlobeNewswire October 27, 2016

Spectranetics Announces Third Quarter 2016 Conference Call and Upcoming Webcast at the Transcatheter Cardiovascular Therapeutics Conference

GlobeNewswire October 6, 2016

Research Reports Initiation on Healthcare Stocks -- NuVasive, Nevro, Spectranetics, and NovoCure

PR Newswire October 6, 2016

Technical Roundup on Medical Appliances & Equipment Stocks -- Zimmer Biomet, Stryker, ABIOMED, and Spectranetics

PR Newswire August 18, 2016

First Randomized Trial of the Stellarex™ Drug-coated Balloon Presented at the Amputation Prevention Symposium

GlobeNewswire August 10, 2016

Spectranetics Receives CE Mark for AngioSculptX™

GlobeNewswire August 10, 2016

Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million

GlobeNewswire July 28, 2016

Federal Circuit Court Rules in Appeal

GlobeNewswire July 21, 2016

12-month Results of the ILLUMENATE European Randomized Clinical Trial to be Presented at the Amputation Prevention Symposium

GlobeNewswire July 20, 2016

Spectranetics to Host Second Quarter 2016 Conference Call on July 28, 2016

GlobeNewswire July 7, 2016

How are These Healthcare Stocks Faring? - Zimmer Biomet, Wright Medical, Spectranetics and Prestige Brands

PR Newswire June 3, 2016

Second Interim Analysis on ILLUMENATE Global Study Presented on Spectranetics’ Stellarex drug-coated balloon at NCVH

GlobeNewswire June 1, 2016

Spectranetics to Present at the UBS Global Healthcare Conference

GlobeNewswire May 11, 2016

Spectranetics Achieves First Quarter 2016 Revenue of $62.9 million

GlobeNewswire April 28, 2016

12-Month Interim ILLUMENATE Global Study Data Presented on Spectranetics' Stellarex drug-coated balloon at Charing Cross

GlobeNewswire April 26, 2016

Spectranetics to Host First Quarter 2016 Conference Call on April 28, 2016

GlobeNewswire April 7, 2016

Spectranetics Names Udo Scheiner as Senior Vice President, International Operations

GlobeNewswire March 24, 2016

Spectranetics Achieves Fourth Quarter 2015 Revenue of $65.2 Million

GlobeNewswire February 25, 2016

QT Vascular Announces Another Positive Outcome in Litigation with Spectranetics/Angioscore

PR Newswire February 10, 2016

Spectranetics to Hold 2015 Fourth Quarter Financial Results Conference Call on February 25, 2016

GlobeNewswire February 9, 2016